Changes of biochemical markers of bone turnover and YKL-40 following hormonal treatment for metastatic prostate cancer are related to survival
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning
Elevated serum levels of biochemical markers of bone turnover and YKL-40 in patients with metastatic prostate cancer (PC) at the time of diagnosis are associated to poor prognosis. In this study, we evaluated the value of these biomarkers in monitoring the patients during hormonal treatment.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Clinical Cancer Research |
Vol/bind | 13 |
Udgave nummer | 11 |
Sider (fra-til) | 3244-9 |
Antal sider | 6 |
ISSN | 1078-0432 |
DOI | |
Status | Udgivet - 1 jun. 2007 |
ID: 34081387